On the stock market since 2024, it operates in the world of money and finance. It has 2 employees. Now — the numbers.
This is an established company with proven profits.
Red columns mark years that ended in a loss.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
For a bank, strength is measured by capital buffers and reserves — not cash minus debt.
Clearly below the class average.
The stock has been running stronger than the market lately.
Financial Strength: The capital buffer looks thin next to its class; less room to absorb a rough stretch.
Business Quality: Profit power and business quality trail similar companies in the sector.
The stock trades 55% below its peak. The market has trimmed its expectations for the company.
Nothing in the current numbers stands out as a strong positive. That, by itself, is worth knowing.
The stock sits at $0.14. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The balance sheet offers little cushion against a rough stretch. Report-card grade: 21/100.
Measured against its sector, the quality of the business sits below the class average. Report-card grade: 28/100.
On our five-subject report card, NOEMR sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: NOEMR is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.
The total grade weighs these five subjects against the sector — it isn’t a simple average of the five.